Pfizer’s decision to halt further marketing of Beqvez is further sign of the sparse patient interest in gene therapies for the bleeding condition.

Positve overall survival data could lead to a label expansion for Pfizer's combination to treat metastatic ...

Pfizer terminated partnership with Sangamo on hemophilia A gene therapy despite positive Phase 3 data. Find out why SGMO ...

Early onset Alzheimer’s disease is Alzheimer’s disease that starts before age 65. It’s rare under age 30 and more commonly affects people ages 50 and over. Early detection and treatment can ...

Objective To investigate the humoral and cellular immune response to messenger RNA (mRNA) COVID-19 vaccines in patients with immune-mediated inflammatory diseases (IMIDs) on immunomodulatory treatment ...

Amicus Therapeutics announced that it will showcase two oral presentations and 20 posters related to its research on Fabry and Pompe diseases at the 21st Annual WORLDSymposium™ 2025 taking place ...

“As part of our ongoing efforts to advance our scientific leadership in Fabry and Pompe diseases, Amicus researchers will present two oral presentations and 20 posters at this year’s WORLDSymposium,” ...

However, its role in fibrotic diseases has not been investigated so far ... JB Therapeutics, Medac, MSD, Pfizer, Roche/Genetech/Chugai and UCB, JHWD has received research funding from AbbVie, AnaMar, ...

Sexually transmitted infections (STIs) usually pass from one person to another through sexual contact. Examples include chlamydia, crabs, and genital herpes. Treatment depends on the type of STI ...

ABU DHABI, 13th June, 2017 (WAM) -- The Ministry of Health and Prevention has signed an agreement with Pfizer-Gulf to raise local community awareness on infectious diseases and highlight the role of ...

a sickle cell disease (“SCD”) therapy, serves as a cautionary tale. After paying >$5.5bn to acquire Global Blood Therpeutics and its lead commercial drug Oxbryta, Pfizer has had to withdraw ...